FDA Warning Letter — Jubilant Generics Limited
The FDA took a Warning Letter action against Jubilant Generics Limited on March 6, 2019 (Bhagwanpur, India). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Jubilant Generics Limited
- Date
- March 6, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Bhagwanpur (India)